Equity Is there hope for digital health startups post-Roe?
May 18, 2022
Kiki Freedman, CEO and co-founder of Hey Jane, a telehealth company specializing in abortion pills, dives into the impact of changing abortion laws on digital health startups. She discusses the delicate balance between fundraising and regulatory scrutiny in a post-Roe world. The conversation highlights the importance of social responsibility in business and creative strategies to address pressing health needs. Kiki also emphasizes telemedicine's vital role in enhancing access to care while navigating the complex legal landscape that affects women's health services.
AI Snips
Chapters
Transcript
Episode notes
Hey Jane's Origin
- Kiki Freedman's idea for Hey Jane originated from a conversation with college friends about Missouri's sole abortion clinic's near closure.
- This sparked her interest in applying the digital health model to abortion access.
Telemedicine Abortion Legality
- Mailing abortion pills was legally ambiguous before COVID, but the FDA's deregulation during the pandemic changed this.
- Despite this positive shift, conflicting state laws create a challenging landscape for telehealth abortion.
Post-Roe World
- The overturning of Roe v. Wade has shifted the conversation around abortion access significantly.
- Despite the challenges, technology and medication abortion offer new possibilities for access compared to the pre-Roe era.